Filing Details

Accession Number:
0001127602-10-010660
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-06 13:00:00
Reporting Period:
2010-04-05
Filing Date:
2010-04-06
Accepted Time:
2010-04-06 14:55:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882796 Biocryst Pharmaceuticals Inc BCRX Biological Products, (No Disgnostic Substances) (2836) 621413174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1410397 Stuart Grant 2190 Parkway Lake Drive
Birmingham AL 35244-
Sr Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-05 1,249 $1.20 12,966 No 4 M Direct
Common Stock Disposition 2010-04-05 1,236 $6.96 11,730 No 4 S Direct
Common Stock Disposition 2010-04-05 13 $6.97 11,717 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Emp. Stock Option (Right to Buy) Disposition 2010-04-05 1,249 $0.00 1,249 $1.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
108,751 2010-03-02 2019-03-02 No 4 M Direct
Footnotes
  1. Transacted under a 10b5-1 plan that was adopted on 11/23/2009.